(ACRS) Aclaris Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Aclaris Therapeutics | (ACRS) share price targets
Complete technical analysis of Aclaris Therapeutics (ACRS) by charts plus indicators, forecast predictions and share price targets for Aclaris Therapeutics (ACRS)
Aclaris Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Aclaris Therapeutics is 959629
| Date | Daily Closing Price | Open | High | Low | Volume |
| 31 Wed Dec 2025 | 3.01 | 2.90 | 3.03 | 2.90 | 0.483 times |
| 30 Tue Dec 2025 | 2.90 | 3.02 | 3.02 | 2.88 | 0.391 times |
| 29 Mon Dec 2025 | 3.01 | 3.02 | 3.05 | 2.98 | 0.455 times |
| 26 Fri Dec 2025 | 3.04 | 3.01 | 3.05 | 2.99 | 0.438 times |
| 24 Wed Dec 2025 | 3.04 | 2.91 | 3.09 | 2.91 | 0.459 times |
| 23 Tue Dec 2025 | 2.90 | 3.05 | 3.06 | 2.78 | 1.798 times |
| 22 Mon Dec 2025 | 3.08 | 3.14 | 3.15 | 3.03 | 0.449 times |
| 19 Fri Dec 2025 | 3.14 | 3.09 | 3.23 | 3.05 | 2.57 times |
| 18 Thu Dec 2025 | 3.08 | 3.03 | 3.15 | 3.03 | 0.712 times |
| 17 Wed Dec 2025 | 3.03 | 3.37 | 3.37 | 3.03 | 0.902 times |
My analysis of stock is bearish for shortterm, and stock might move down till 2.9 or till 2.8. Use a stoploss of 3.08 and if the stock hits stoploss, then it can shoot up till 3.23
Share price targets for Aclaris Therapeutics (ACRS)
| Target Type | Value |
| Downside Target | 1.50 |
| Downside Target | 1.74 |
| Downside Target | 1.81 |
| Downside Target | 1.98 |
| Downside Target | 2.10 |
| Downside Target | 2.15 |
| Downside Target | 2.59 |
| Downside Target | 2.78 |
| Downside Target | 2.88 |
| Upside Target | 3.03 |
| Upside Target | 3.08 |
| Upside Target | 3.15 |
| Upside Target | 3.39 |
| Upside Target | 3.48 |
Intraday share price targets for Aclaris Therapeutics (ACRS)
| Target Type | Value |
| Downside Intraday Target | 2.91 |
| Downside Intraday Target | 2.81 |
| Upside Intraday Target | 3.08 |
| Upside Intraday Target | 3.15 |
| Downside Intraday Target | 2.98 |
Weekly technical analysis of Aclaris Therapeutics (ACRS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 31 Wed Dec 2025 | 3.01 | 3.02 | 3.05 | 2.88 | 0.423 times |
| 26 Fri Dec 2025 | 3.04 | 3.14 | 3.15 | 2.78 | 0.413 times |
| 19 Fri Dec 2025 | 3.14 | 3.25 | 3.39 | 3.03 | 0.873 times |
| 12 Fri Dec 2025 | 3.25 | 2.99 | 3.48 | 2.93 | 1.406 times |
| 05 Fri Dec 2025 | 2.92 | 2.79 | 3.08 | 2.59 | 1.272 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Aclaris Therapeutics (ACRS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 31 Wed Dec 2025 | 3.01 | 2.79 | 3.48 | 2.59 | 1.051 times |
| 28 Fri Nov 2025 | 2.83 | 2.50 | 2.92 | 2.10 | 0.835 times |
| 31 Fri Oct 2025 | 2.52 | 1.89 | 2.62 | 1.74 | 1.295 times |
| 30 Tue Sep 2025 | 1.90 | 1.93 | 2.15 | 1.81 | 1.444 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Aclaris Therapeutics (ACRS)
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Aclaris Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Aclaris Therapeutics in short term but the sell signal is initial and weak.
Aclaris Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Aclaris Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Aclaris Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.04 and Aclaris Therapeutics (ACRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aclaris Therapeutics (ACRS) stock. Volume based technical analysis of Aclaris Therapeutics (ACRS) stock is negative.
Aclaris Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Aclaris Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Aclaris Therapeutics in short term but the sell signal is initial and weak.
Aclaris Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Aclaris Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Aclaris Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.04 and Aclaris Therapeutics (ACRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aclaris Therapeutics (ACRS) stock. Volume based technical analysis of Aclaris Therapeutics (ACRS) stock is negative.
Aclaris Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.